CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer
CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer
Not yet recruiting · NCT07057349 · Registry updated 2025-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Not yet recruiting | Phase 1 | 2025-07-09 | NCT07057349 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cytosite Biopharma Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |